How to beat apremilast-induced diarrhea
MAUI, HAWAII – If you’re going to prescribe apremilast for psoriasis or psoriatic arthritis – and more and more physicians are doing so because of the drug’s exceptional safety profile – you’d better... (Source: Rheumatology News)
Source: Rheumatology News - April 13, 2016 Category: Rheumatology Source Type: research
Rosacea linked to several autoimmune diseases in women
Rosacea in women is linked with an increased risk for a wide variety of autoimmune disorders including type 1 diabetes, celiac disease, multiple sclerosis, and rheumatoid arthritis, according to a... (Source: Rheumatology News)
Source: Rheumatology News - April 13, 2016 Category: Rheumatology Source Type: research
Small fiber neuropathy common, vexing in sarcoidosis
MAUI, HAWAII – Small fiber neuropathy is a common and underappreciated expression of systemic sarcoidosis, Dr. Alvin F. Wells observed at the 2016 Rheumatology Winter Clinical Symposium.
Small... (Source: Rheumatology News)
Source: Rheumatology News - April 12, 2016 Category: Rheumatology Source Type: research
Osteoarthritis hip pain follows four distinct paths
AMSTERDAM – There are four distinct patterns of pain in patients with early presumed hip osteoarthritis, and several factors could help identify patients most likely to experience more severe pain,... (Source: Rheumatology News)
Source: Rheumatology News - April 10, 2016 Category: Rheumatology Source Type: research
Medicare Part B drug payment proposal could cost some doctors
Physicians could be facing a cut in reimbursement for drugs administered in their offices that cost more than $480, according to an Avalere analysis of the proposed Medicare Part B drug payment... (Source: Rheumatology News)
Source: Rheumatology News - April 9, 2016 Category: Rheumatology Source Type: research
Sustained-release steroid provides prolonged OA pain relief
AMSTERDAM – A single intra-articular injection of a novel corticosteroid formulation provided substantial and persistent pain relief for at least 12 weeks in patients with knee osteoarthritis in a... (Source: Rheumatology News)
Source: Rheumatology News - April 9, 2016 Category: Rheumatology Source Type: research
Clazakizumab safe, effective for PsA treatment
Treatment with clazakizumab was well tolerated and effective at treating musculoskeletal stress in patients with psoriatic arthritis (PsA), Dr. Philip Mease and his associates reported in a phase IIB... (Source: Rheumatology News)
Source: Rheumatology News - April 8, 2016 Category: Rheumatology Source Type: research
Persistent knee pain predicts structural osteoarthritis early
AMSTERDAM – Persistent knee pain is an important predictor of structural joint damage and could potentially be used to predict knee osteoarthritis (OA) earlier, according to Dutch research reported... (Source: Rheumatology News)
Source: Rheumatology News - April 8, 2016 Category: Rheumatology Source Type: research
Less symptomatic patients ‘worse off’ after knee surgery
AMSTERDAM – Patients with milder knee osteoarthritis symptoms or better quality of life before undergoing total knee replacement surgery gained less benefit from the surgery than did those who had... (Source: Rheumatology News)
Source: Rheumatology News - April 8, 2016 Category: Rheumatology Source Type: research
Study details synovial features in RA remission and shift back to active disease
Macrophage infiltration into the synovium may be a feature of rheumatoid arthritis that persists in both patients with clinically active disease and those who are in clinical remission, while higher... (Source: Rheumatology News)
Source: Rheumatology News - April 8, 2016 Category: Rheumatology Source Type: research
SURVEY: Telemedicine high priority, but reimbursement remains challenging
Nearly two-thirds of health care providers rank telemedicine as a top priority in 2016, a 10% increase from last year, according to a survey.
Telemedicine software company REACH Health surveyed 390... (Source: Rheumatology News)
Source: Rheumatology News - April 7, 2016 Category: Rheumatology Source Type: research
Inflectra becomes first FDA-approved biosimilar for inflammatory diseases
A biosimilar version of the anti–tumor necrosis factor–alpha agent Remicade has been approved by the Food and Drug Administration, making it the first biosimilar drug approved by the agency for... (Source: Rheumatology News)
Source: Rheumatology News - April 5, 2016 Category: Rheumatology Source Type: research
Could value-based care raise False Claims Act liability?
As you begin to consider the switch to value-based care systems, be sure to safeguard against risks that could fuel false claims scrutiny by the government, legal experts advise.
A primary... (Source: Rheumatology News)
Source: Rheumatology News - April 5, 2016 Category: Rheumatology Source Type: research
EHR Report: Take your medicine!
“Drugs don’t work in patients who don’t take them.”
–C. Everett Koop, M.D.
While it would be hard to imagine accountable care organizations being able to get the data they need to... (Source: Rheumatology News)
Source: Rheumatology News - April 5, 2016 Category: Rheumatology Source Type: research
State board discipline of physicians varies widely by state
The rate at which medical boards discipline physicians varies widely by state, with Delaware doctors facing four times more disciplinary actions that Massachusetts physicians, according to a review... (Source: Rheumatology News)
Source: Rheumatology News - April 4, 2016 Category: Rheumatology Source Type: research
